Matinas Biopharma Holdings, Inc.盘中异动股价大跌9.60%

自选股智能写手04-02

北京时间2024年04月02日21时31分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现波动，股价急速下跌9.60%。截至发稿，该股报0.334美元/股，成交量34.0671万股，换手率0.16%，振幅4.68%。最近的财报数据显示，该股实现营业收入1.10百万美元，净利润-22.94百万美元，每股收益-0.11美元，毛利155000.00美元，市盈率...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2424204353?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-02 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2424204353","market":"us","top_or_hot":-1,"title":"Matinas Biopharma Holdings, Inc.盘中异动 股价大跌9.60%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月02日21时31分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现波动，股价急速下跌9.60%。截至发稿，该股报0.334美元/股，成交量34.0671万股，换手率0.16%，振幅4.68%。最近的财报数据显示，该股实现营业收入1.10百万美元，净利润-22.94百万美元，每股收益-0.11美元，毛利155000.00美元，市盈率...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022131328ae8b857&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Matinas Biopharma Holdings, Inc.盘中异动 股价大跌9.60%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMatinas Biopharma Holdings, Inc.盘中异动 股价大跌9.60%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-02 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022131328ae8b857&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月02日21时31分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现波动，股价急速下跌9.60%。截至发稿，该股报0.334美元/股，成交量34.0671万股，换手率0.16%，振幅4.68%。最近的财报数据显示，该股实现营业收入1.10百万美元，净利润-22.94百万美元，每股收益-0.11美元，毛利155000.00美元，市盈率...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022131328ae8b857&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022131328ae8b857&s=b","article_id":"2424204353","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022131328ae8b857&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2424204353","pubTimestamp":1712064692,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月02日21时31分，Matinas Biopharma Holdings, Inc.股票出现波动，股价急速下跌9.60%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.14%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，致力于发现和开发源自其脂质晶体纳米颗粒或耳蜗递送技术平台的候选产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","MTNB":"Matinas BioPharma Holdings, Inc"},"translate_title":"Matinas Biopharma Holdings, Inc. shares fell 9.60% in intraday trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MTNB":0.9},"content_text":"北京时间2024年04月02日21时31分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现波动，股价急速下跌9.60%。截至发稿，该股报0.334美元/股，成交量34.0671万股，换手率0.16%，振幅4.68%。最近的财报数据显示，该股实现营业收入1.10百万美元，净利润-22.94百万美元，每股收益-0.11美元，毛利155000.00美元，市盈率-3.04倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.14%。其相关个股中，Aditxt, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 (To Pur Com)、Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)涨幅较大，Aditxt, Inc.、Imunon, Inc.、Vbi Vaccines, Inc.较为活跃，换手率分别为404.22%、10.34%、10.10%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 (To Pur Com)、Aditxt, Inc.、Boundless Bio, Inc.，振幅分别为48.62%、15.72%、10.19%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，致力于发现和开发源自其脂质晶体纳米颗粒或耳蜗递送技术平台的候选产品。 该公司的产品线包括MAT2203，MAT2501等。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2424204353"}

Matinas Biopharma Holdings, Inc.盘中异动 股价大跌9.60%

精彩评论

Matinas Biopharma Holdings, Inc.盘中异动股价大跌9.60%